Swiss eyecare firm Alcon said on Monday it has agreed to a deal worth a potential $430 million with US counterpart Lensar, which offers advanced laser solutions for cataract treatments.
This article was originally published on this website.
Swiss meditech Alcon inks eyecare deal with US’s Lensar
